Back to search

Peptide record

TPDB18178

Antibacterial standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB18178
Antibacterial
Anti-infective peptides
Peptipedia
standard
No
A 33-aa standard natural antibacterial peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
ASKKGKCNLLCKLKQKLRSVGAGTHIGSVVLKG
Physicochemical Analysis
C149H269N47O40S2
DEMFPWY
K
3423.19
10.91
9
0
11
+8
6.56
-0.073
103.33
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
125
3.65
8
Residue Composition
number
2
A
1
R
1
N
0
D
2
C
0
E
1
Q
5
G
1
H
1
I
5
L
7
K
0
M
0
F
0
P
3
S
1
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 2 R: 1 N: 1 D: 0 C: 2 E: 0 Q: 1 G: 5 H: 1 I: 1 L: 5 K: 7 M: 0 F: 0 P: 0 S: 3 T: 1 W: 0 Y: 0 V: 3
Chemical Descriptors
33
C149H269N47O40S2
3423.19
10.91
+8
6.56
-0.073
Evidence Records 8 records
Evidence 1 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

V. alginolyticus ATCC17749

Source & Reference

NA

Other

Active against Gram+ S. aureus, Gram- V. alginolyticus ATCC17749 (MIC 100 ug/ml), V. parahaemolyticus ATCC33847 (MIC 6.25 ug/ml), V. harveyi ATCC33866 (MIC 25 ug/ml), V.
Evidence 2 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

V. parahaemolyticus ATCC33847

Source & Reference

NA

Other

Active against Gram+ S. aureus, Gram- V. alginolyticus ATCC17749 (MIC 100 ug/ml), V. parahaemolyticus ATCC33847 (MIC 6.25 ug/ml), V. harveyi ATCC33866 (MIC 25 ug/ml), V. anguillarum ATCC19264 (MIC > 100 ug/ml), E. coli
Evidence 3 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

V. harveyi ATCC33866

Source & Reference

NA

Other

alginolyticus ATCC17749 (MIC 100 ug/ml), V. parahaemolyticus ATCC33847 (MIC 6.25 ug/ml), V. harveyi ATCC33866 (MIC 25 ug/ml), V. anguillarum ATCC19264 (MIC > 100 ug/ml), E. coli K12 (MIC 50 ug/ml), E. tarda Et-CD (
Evidence 4 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

Escherichia coli K12

Source & Reference

NA

Other

ug/ml), V. harveyi ATCC33866 (MIC 25 ug/ml), V. anguillarum ATCC19264 (MIC > 100 ug/ml), E. coli K12 (MIC 50 ug/ml), E. tarda Et-CD (MIC 50 ug/ml), S. aureus ATCC6538 (MIC 6.25 ug/ml), the pathogenic bacte
Evidence 5 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

E. tarda Et-CD

Source & Reference

NA

Other

6 (MIC 25 ug/ml), V. anguillarum ATCC19264 (MIC > 100 ug/ml), E. coli K12 (MIC 50 ug/ml), E. tarda Et-CD (MIC 50 ug/ml), S. aureus ATCC6538 (MIC 6.25 ug/ml), the pathogenic bacterium A. hydrophila ATCC7966 (MI
Evidence 6 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

Staphylococcus aureus ATCC6538

Source & Reference

NA

Other

m ATCC19264 (MIC > 100 ug/ml), E. coli K12 (MIC 50 ug/ml), E. tarda Et-CD (MIC 50 ug/ml), S. aureus ATCC6538 (MIC 6.25 ug/ml), the pathogenic bacterium A. hydrophila ATCC7966 (MIC 25 ug/ml), L.monocytogeness (MIC >1
Evidence 7 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

A. hydrophila ATCC7966

Source & Reference

NA

Other

tarda Et-CD (MIC 50 ug/ml), S. aureus ATCC6538 (MIC 6.25 ug/ml), the pathogenic bacterium A. hydrophila ATCC7966 (MIC 25 ug/ml), L.monocytogeness (MIC >100 ug/ml), and S. iniae (MIC > 100 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
>100 µg/mL

Target

L.monocytogeness

Source & Reference

NA

Other

TCC6538 (MIC 6.25 ug/ml), the pathogenic bacterium A. hydrophila ATCC7966 (MIC 25 ug/ml), L.monocytogeness (MIC >100 ug/ml), and S. iniae (MIC > 100 ug/ml).